Market Research Logo

Global Drugs for Vulvovaginal Candidiasis Market Research Report 2018

Global Drugs for Vulvovaginal Candidiasis Market Research Report 2018

This report studies the Drugs for Vulvovaginal Candidiasis market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Drugs for Vulvovaginal Candidiasis market by product type and applications.

In the last several years, global market of Drugs for Vulvovaginal Candidiasis developed steadily, with an average growth rate of 5.5%. In 2017, global sales revenue of Drugs for Vulvovaginal Candidiasis is nearly 770 M USD; the actual sale is about 175 million units.

The major players in global Drugs for Vulvovaginal Candidiasis market include
Bayer
Perrigo
J & J
Pfizer
Bristol-Myers Squibb
Effik
Teva
Sanofi
Cisen Pharmaceutical
Kingyork Group

Geographically, this report is segmented into several key Regions, with Sales, revenue, Market Share (%) and Growth Rate (%) of Drugs for Vulvovaginal Candidiasis in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
Asia-Pacific
South America
Middle East and Africa

On the basis of Formulation Types, the Drugs for Vulvovaginal Candidiasis market is primarily split into
Cream
Pessary
Other

On the basis of drugs types, the Drugs for Vulvovaginal Candidiasis market is primarily split into
Miconazole
Clotrimazole
Fluconazole
Econazole
Other

On the basis on the end applications, this report covers
Hospital & Clinic
Pharmacy


1 Drugs for Vulvovaginal Candidiasis Market Overview
1.1 Drugs for Vulvovaginal Candidiasis Product Overview
1.2 Drugs for Vulvovaginal Candidiasis Segment by Types (Product Category)
1.2.1 Global Drugs for Vulvovaginal Candidiasis Sales and Growth (%) Comparison by Formulation Types
1.2.2 Global Drugs for Vulvovaginal Candidiasis Sales and Growth (%) Comparison by Drugs Types
1.3 Global Drugs for Vulvovaginal Candidiasis Segment by Applications
1.4 Global Drugs for Vulvovaginal Candidiasis Market by Regions (2013-2025)
1.4.1 Global Drugs for Vulvovaginal Candidiasis Market Size and Growth (%) Comparison by Regions (2013-2025)
1.4.2 North America Drugs for Vulvovaginal Candidiasis Status and Prospect (2013-2025)
1.4.3 Asia-Pacific Drugs for Vulvovaginal Candidiasis Status and Prospect (2013-2025)
1.4.4 Europe Drugs for Vulvovaginal Candidiasis Status and Prospect (2013-2025)
1.4.5 South America Drugs for Vulvovaginal Candidiasis Status and Prospect (2013-2025)
1.4.6 Middle East and Africa Drugs for Vulvovaginal Candidiasis Status and Prospect (2013-2025)
1.5 Global Drugs for Vulvovaginal Candidiasis Market Size (2013-2025)
1.5.1 Global Drugs for Vulvovaginal Candidiasis Revenue Status and Outlook (2013-2025)
1.5.2 Global Drugs for Vulvovaginal Candidiasis Sales Status and Outlook (2013-2025)
2 Global Drugs for Vulvovaginal Candidiasis Market Competition by Manufacturers/Brand
2.1 Global Drugs for Vulvovaginal Candidiasis Sales and Share by Manufacturers (2016-2017)
2.2 Global Drugs for Vulvovaginal Candidiasis Revenue and Share by Manufacturers (2016-2017)
2.3 Global Drugs for Vulvovaginal Candidiasis Average Price by Manufacturers (2016-2017)
2.4 Manufacturers Drugs for Vulvovaginal Candidiasis Headquarter, Founded Date
2.5 Drugs for Vulvovaginal Candidiasis Market Competitive Situation and Trends
2.5.1 Drugs for Vulvovaginal Candidiasis Market Concentration Rate
2.5.2 Drugs for Vulvovaginal Candidiasis Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Drugs for Vulvovaginal Candidiasis Sales, Revenue by Regions (2013-2018)
3.1 Global Drugs for Vulvovaginal Candidiasis Sales and Market Share by Regions (2013-2018)
3.2 Global Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Regions (2013-2018)
3.3 Global Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2013-2018)
3.4 North America Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2013-2018)
3.5 Europe Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2013-2018)
3.5.1 Europe Drugs for Vulvovaginal Candidiasis Sales and Revenue by Regions
3.5.2 Europe Drugs for Vulvovaginal Candidiasis Sales, Price and Revenue by Regions
3.6 Asia-Pacific Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2013-2018)
3.7 South America Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2013-2018)
3.8 Middle East and Africa Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2013-2018)
4 Global Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price Trend by Types
4.1 Global Drugs for Vulvovaginal Candidiasis by Formulation Types
4.1.1 Global Drugs for Vulvovaginal Candidiasis Sales and Market Share by Formulation Types (2013-2018)
4.1.2 Global Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Formulation Types (2013-2018)
4.1.3 Global Drugs for Vulvovaginal Candidiasis Price by Formulation Type (2013-2018)
4.2 Global Drugs for Vulvovaginal Candidiasis by Drugs Types
4.2.1 Global Drugs for Vulvovaginal Candidiasis Sales and Market Share by Drugs Types (2013-2018)
4.2.2 Global Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Drugs Types (2013-2018)
4.2.3 Global Drugs for Vulvovaginal Candidiasis Price by Drugs Type (2013-2018)
5 Global Drugs for Vulvovaginal Candidiasis Market Analysis by Applications
5.1 Global Drugs for Vulvovaginal Candidiasis Sales and Market Share by Applications (2013-2018)
5.2 Global Drugs for Vulvovaginal Candidiasis Sales Growth Rate by Applications (2013-2018)
6 Analysis of Drugs for Vulvovaginal Candidiasis Industry Key Manufacturers
6.1 Bayer
6.1.1 Company Profile
6.1.2 Product Information
6.1.3 Sales, Price, Cost, Gross, and Revenue
6.2 Perrigo
6.2.1 Company Profile
6.2.2 Product Information
6.2.3 Sales, Price, Cost, Gross, and Revenue
6.3 J & J
6.3.1 Company Profile
6.3.2 Product Information
6.3.3 Sales, Price, Cost, Gross, and Revenue
6.4 Pfizer
6.4.1 Company Profile
6.4.2 Product Information
6.4.3 Sales, Price, Cost, Gross, and Revenue
6.5 Bristol-Myers Squibb
6.5.1 Company Profile
6.5.2 Product Information
6.5.3 Sales, Price, Cost, Gross, and Revenue
6.6 Effik
6.6.1 Company Profile
6.6.2 Product Information
6.6.3 Sales, Price, Cost, Gross, and Revenue
6.7 Teva
6.7.1 Company Profile
6.7.2 Product Information
6.7.3 Sales, Price, Cost, Gross, and Revenue
6.8 Sanofi
6.8.1 Company Profile
6.8.2 Product Information
6.8.3 Sales, Price, Cost, Gross, and Revenue
6.9 Cisen Pharmaceutical
6.9.1 Company Profile
6.9.2 Product Information
6.9.3 Sales, Price, Cost, Gross, and Revenue
6.10 Kingyork Group
6.10.1 Company Profile
6.10.2 Product Information
6.10.3 Sales, Price, Cost, Gross, and Revenue
7 Drugs for Vulvovaginal Candidiasis Manufacturing Cost Analysis
7.1 Drugs for Vulvovaginal Candidiasis R&D Cost Analysis
7.1.1 Clinical Phase Costs
7.1.2 Capitalized Costs
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Other Costs Analysis
7.2.4 Manufacturing Expenses
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Drugs for Vulvovaginal Candidiasis Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 Global Drugs for Vulvovaginal Candidiasis Market Forecast (2019-2025)
11.1 Global Drugs for Vulvovaginal Candidiasis Sales, Revenue Forecast (2019-2025)
11.1.1 Global Drugs for Vulvovaginal Candidiasis Sales and Growth Rate Forecast (2019-2025)
11.1.2 Global Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Drugs for Vulvovaginal Candidiasis Price and Trend Forecast (2019-2025)
11.2 Global Drugs for Vulvovaginal Candidiasis Sales and Revenue Forecast by Regions (2019-2025)
11.2.1 North America Drugs for Vulvovaginal Candidiasis Sales and Revenue Forecast (2019-2025)
11.2.2 Europe Drugs for Vulvovaginal Candidiasis Sales and Revenue Forecast (2019-2025)
11.2.3 Asia-Pacific Drugs for Vulvovaginal Candidiasis Sales and Revenue Forecast (2019-2025)
11.2.4 South America Drugs for Vulvovaginal Candidiasis Sales and Revenue Forecast (2019-2025)
11.2.5 Middle East and Africa Drugs for Vulvovaginal Candidiasis Sales and Revenue Forecast (2019-2025)
11.3 Global Drugs for Vulvovaginal Candidiasis Sales Forecast by Type (2019-2025)
11.3.1 Global Drugs for Vulvovaginal Candidiasis by Formulation Types
11.3.2 Global Drugs for Vulvovaginal Candidiasis by Drugs Types
11.4 Global Drugs for Vulvovaginal Candidiasis Sales Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables and Figures
Figure Drugs for Vulvovaginal Candidiasis Picture
Table Global Drugs for Vulvovaginal Candidiasis Sales (K Unit) and Growth Rate (%) Comparison by Formulation Types (2013-2025)
Figure Global Drugs for Vulvovaginal Candidiasis Sales Market Share (%) by Formulation Types in 2017
Figure Product Picture of Cream
Figure Product Picture of Pessary
Table Global Drugs for Vulvovaginal Candidiasis Sales (K Unit) and Growth Rate (%) Comparison by Drugs Types (2013-2025)
Figure Global Drugs for Vulvovaginal Candidiasis Sales Market Share (%) by Drugs Types in 2017
Figure Product Picture of Miconazole
Figure Product Picture of Clotrimazole
Figure Product Picture of Fluconazole
Figure Product Picture of Econazole
Table Global Drugs for Vulvovaginal Candidiasis Sales (K Unit) and Growth Rate (%) Comparison by Applications (2013-2025)
Figure Global Drugs for Vulvovaginal Candidiasis Sales Market Share (%) by Applications in 2017
Table Global Market Drugs for Vulvovaginal Candidiasis Revenue (M USD) Comparison by Regions 2013-2025
Figure North America Drugs for Vulvovaginal Candidiasis Revenue (M USD) and Growth Rate (%) (2013-2025)
Figure Asia-Pacific Drugs for Vulvovaginal Candidiasis Revenue (M USD) and Growth Rate (%) (2013-2025)
Figure Europe Drugs for Vulvovaginal Candidiasis Revenue (M USD) and Growth Rate (%) (2013-2025)
Figure South America Drugs for Vulvovaginal Candidiasis Revenue (M USD) and Growth Rate (%) (2013-2025)
Figure Middle East and Africa Drugs for Vulvovaginal Candidiasis Revenue (M USD) and Growth Rate (%) (2013-2025)
Figure Global Drugs for Vulvovaginal Candidiasis Revenue (M USD) Status and Outlook (2013-2025)
Figure Global Drugs for Vulvovaginal Candidiasis Sales (K Unit) Status and Outlook (2013-2025)
Table Global Drugs for Vulvovaginal Candidiasis Sales (K Unit) of Key Manufacturers (2016-2017)
Table Global Drugs for Vulvovaginal Candidiasis Sales Share (%) by Manufacturers (2016-2017)
Figure 2016 Drugs for Vulvovaginal Candidiasis Sales Share (%) by Manufacturers
Figure 2017 Drugs for Vulvovaginal Candidiasis Sales Share (%) by Manufacturers
Table Global Drugs for Vulvovaginal Candidiasis Revenue (M USD) by Manufacturers (2016-2017)
Table Global Drugs for Vulvovaginal Candidiasis Revenue Share (%) by Manufacturers (2016-2017)
Figure 2016 Global Drugs for Vulvovaginal Candidiasis Revenue Share (%) by Manufacturers
Figure 2017 Global Drugs for Vulvovaginal Candidiasis Revenue Share (%) by Manufacturers
Table Global Market Drugs for Vulvovaginal Candidiasis Average Price (USD/Unit) of Key Manufacturers (2016-2017)
Figure Global Market Drugs for Vulvovaginal Candidiasis Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Drugs for Vulvovaginal Candidiasis Headquarter and Sales Area
Figure Drugs for Vulvovaginal Candidiasis Revenue Market Concentration Rate in 2017
Figure Drugs for Vulvovaginal Candidiasis Revenue Market Share (%) of Top 3 Manufacturers in 2017
Figure Drugs for Vulvovaginal Candidiasis Revenue Market Share (%) of Top 5 Manufacturers in 2017
Table Global Drugs for Vulvovaginal Candidiasis Sales (K Unit) by Regions (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Sales Market Share (%) by Regions (2013-2018)
Figure Global Drugs for Vulvovaginal Candidiasis Sales Market Share (%) by Regions (2013-2018)
Figure 2017 Global Drugs for Vulvovaginal Candidiasis Sales Market Share (%) by Regions
Table Global Drugs for Vulvovaginal Candidiasis Revenue (M USD) by Regions (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Revenue Market Share (%) by Regions (2013-2018)
Figure Global Drugs for Vulvovaginal Candidiasis Revenue Market Share by Regions (2013-2018)
Figure 2017 Global Drugs for Vulvovaginal Candidiasis Revenue Market Share by Regions
Table Global Drugs for Vulvovaginal Candidiasis Sales (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (%) (2013-2018)
Table North America Drugs for Vulvovaginal Candidiasis Sales (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (%) (2013-2018)
Table Europe Drugs for Vulvovaginal Candidiasis Sales (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (%) (2013-2018)
Table Europe Drugs for Vulvovaginal Candidiasis Sales (K Unit) and Market Share by Regions (2013-2018)
Table Europe Drugs for Vulvovaginal Candidiasis Revenue (M USD) and Market Share by Regions (2013-2018)
Table Sweden Drugs for Vulvovaginal Candidiasis Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018)
Table Norway Drugs for Vulvovaginal Candidiasis Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018)
Table Finland Drugs for Vulvovaginal Candidiasis Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018)
Table Denmark Drugs for Vulvovaginal Candidiasis Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018)
Table Asia-Pacific Drugs for Vulvovaginal Candidiasis Sales (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (%) (2013-2018)
Table South America Drugs for Vulvovaginal Candidiasis Sales (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (%) (2013-2018)
Table Middle East and Africa Drugs for Vulvovaginal Candidiasis Sales (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (%) (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Sales (K Unit) by Formulation Types (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Sales Share (%) by Formulation Types (2013-2018)
Figure Sales Market Share (%) of Drugs for Vulvovaginal Candidiasis by Formulation Types (2013-2018)
Figure 2017 Sales Market Share (%) of Drugs for Vulvovaginal Candidiasis by Formulation Types
Table Global Drugs for Vulvovaginal Candidiasis Revenue (M USD) by Formulation Types (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Revenue Share (%) by Formulation Types (2013-2018)
Figure Revenue Share of Drugs for Vulvovaginal Candidiasis by Formulation Types (2013-2018)
Figure 2017 Revenue Market Share (%) of Drugs for Vulvovaginal Candidiasis by Formulation Types
Table Global Drugs for Vulvovaginal Candidiasis Price (USD/Unit) by Formulation Types (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Sales (K Unit) by Drugs Types (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Sales Share (%) by Drugs Types (2013-2018)
Figure Sales Market Share (%) of Drugs for Vulvovaginal Candidiasis by Drugs Types (2013-2018)
Figure 2017 Sales Market Share (%) of Drugs for Vulvovaginal Candidiasis by Drugs Types
Table Global Drugs for Vulvovaginal Candidiasis Revenue (M USD) by Drugs Types (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Revenue Share (%) by Drugs Types (2013-2018)
Figure Revenue Share of Drugs for Vulvovaginal Candidiasis by Drugs Types (2013-2018)
Figure 2017 Revenue Market Share (%) of Drugs for Vulvovaginal Candidiasis by Drugs Types
Table Global Drugs for Vulvovaginal Candidiasis Price (USD/Unit) by Drugs Types (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Sales (K Unit) by Applications (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Sales Market Share (%) by Applications (2013-2018)
Figure Global Drugs for Vulvovaginal Candidiasis Sales Market Share (%) by Applications (2013-2018)
Figure Global Drugs for Vulvovaginal Candidiasis Sales Market Share (%) by Applications in 2017
Figure Global Drugs for Vulvovaginal Candidiasis Sales Growth Rate (%) by Applications (2013-2018)
Table Bayer Company Profile
Figure Drugs for Vulvovaginal Candidiasis Product Picture of Bayer
Table Drugs for Vulvovaginal Candidiasis Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bayer 2016-2017
Table Perrigo Company Profile
Figure Drugs for Vulvovaginal Candidiasis Product Picture of Perrigo
Table Drugs for Vulvovaginal Candidiasis Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Perrigo 2016-2017
Table J & J Company Profile
Figure Drugs for Vulvovaginal Candidiasis Product Picture of J & J
Table Drugs for Vulvovaginal Candidiasis Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of J & J 2016-2017
Table Pfizer Company Profile
Figure Drugs for Vulvovaginal Candidiasis Product Picture of Pfizer
Table Drugs for Vulvovaginal Candidiasis Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2016-2017
Table Bristol-Myers Squibb Company Profile
Figure Drugs for Vulvovaginal Candidiasis Product Picture of Bristol-Myers Squibb
Table Drugs for Vulvovaginal Candidiasis Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bristol-Myers Squibb 2016-2017
Table Effik Company Profile
Figure Drugs for Vulvovaginal Candidiasis Product Picture of Effik
Table Drugs for Vulvovaginal Candidiasis Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Effik 2016-2017
Table Teva Company Profile
Figure Drugs for Vulvovaginal Candidiasis Product Picture of Teva
Table Drugs for Vulvovaginal Candidiasis Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Teva 2016-2017
Table Sanofi Company Profile
Figure Drugs for Vulvovaginal Candidiasis Product Picture of Sanofi
Table Drugs for Vulvovaginal Candidiasis Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi 2016-2017
Table Cisen Pharmaceutical Company Profile
Figure Drugs for Vulvovaginal Candidiasis Product Picture of Cisen Phar

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report